CCTV News: In order to accelerate the industrialization of the new crown vaccine, the Ministry of Industry and Information Technology has specially set up a special class for the production of new crown vaccines to schedule the production capacity construction progress of key enterprises every week.

At present, 18 domestic companies have successively carried out capacity building based on their own new crown vaccine research and development progress.

  Sinopharm Zhongsheng Beijing's new crown inactivated vaccine has obtained conditional marketing approval on December 30.

At present, Sinopharm Zhongsheng has started mass production.

In the new crown vaccine packaging workshop of Zhongsheng Beijing Company, the reporter saw that starting from the opening of the nest, light inspection, rotary rod labeling, boxing, weighing, and coding systems, each vaccine has an electronic ID card, which can The flow of the vaccine is traced back all the way, and where the vaccine goes and who is vaccinated will be recorded.

  Zhang Jin, production leader of the new crown project of Sinopharm Zhongsheng Group Beijing Biological Products Research Institute Co., Ltd.: A packaging line like ours can pack 200,000 doses per day. Our employees gave up their rest days and worked 24 hours for the Spring Festival. There will be more vaccines on the market before, and our production capacity will be expanded to 1 billion doses in 2021 to meet market supply.

  At present, the Ministry of Industry and Information Technology has comprehensively sorted out the entire industrial chain and supply chain of the new coronavirus vaccine, and guided companies to conduct serious research, judgment and analysis on the supply risks of key raw materials, key equipment, and consumables. Do a good job in the connection between upstream and downstream supply and demand to ensure the stability of the new coronavirus vaccine production and supply chain.